January 28, 2009 - SurModics Inc. and Nexeon MedSystems Inc. this week signed a licensing agreement to collaborate on development of a novel stent system for the treatment of renal artery disease.
This agreement is in addition to the prior one announced in July 2007 to develop a novel stent system for coronary artery disease, which is now in clinical trials. SurModics is also an equity investor in Nexeon MedSystems.
